Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
British Journal of Cancer|February 5, 2020
Targeting DUBs to degrade oncogenic proteinsAnjali Cremer, Kimberly StegmaierJournal of Medicinal Chemistry|February 12, 2019
Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring MutationsDennis Bensinger, Daniel Stubba, Anjali Cremer, et al.Best Practice & Research. Clinical Haematology|March 7, 2006
Genomic approaches in acute leukemiaKimberly StegmaierBlood|July 28, 2018
Targeted therapy for fusion-driven high-risk acute leukemiaYana Pikman, Kimberly StegmaierCritical Reviews in Oncogenesis|December 14, 2011
Targeting NOTCH1 in hematopoietic malignancyGiovanni Roti, Kimberly StegmaierCancer Cell|September 13, 2017
Scratching the Surface of Immunotherapeutic Targets in NeuroblastomaClare F Malone, Kimberly StegmaierScientific Reports|April 5, 2025
Inflammatory signaling pathways play a role in SYK inhibitor resistant AMLSarah Tausch, Christina Villinger, Gabriela Alexe, et al.Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A ArmstrongJournal of Medicinal Chemistry|October 27, 2015
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid LeukemiaTheresa Neumann, Lina Benajiba, Stefan Göring, et al.Pageof 18